JAK2 and glioblastoma: Overall, these results represent another evidence that the inhibition of JAK2-STAT5a/b signaling by iPA might provide a possible adjuvant therapy for irradiation of glioblastoma, enhancing the sensitivity to radiation and reducing radiation-induced damage to the neighboring tissues.